Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 55, 2020 - Issue 2
Submit an article Journal homepage
251
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study

Eun Soo KimDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea; View further author information
,
Hyun Seok LeeDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea; View further author information
,
Sung Kook KimDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea; View further author information
,
Eun Young KimDivision of Gastroenterology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea; View further author information
,
Byung Ik JangDivision of Gastroenterology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea; Correspondence[email protected]
View further author information
,
Kyeong Ok KimDivision of Gastroenterology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea; View further author information
,
Chang Heon YangDivision of Gastroenterology, Department of Internal Medicine, Dongguk University School of Medicine, Gyeongju, Korea; View further author information
,
Yoo Jin LeeDivision of Gastroenterology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, KoreaView further author information
& on behalf of the Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD) show all
Pages 163-168 | Received 05 Dec 2019, Accepted 06 Jan 2020, Published online: 26 Jan 2020

References

  • Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713–1725.
  • Choi CH, Moon W, Kim YS, et al. Second Korean guidelines for the management of ulcerative colitis. Intest Res. 2017;15(1):7–37.
  • Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324–1338.
  • (a) Peyrin-Biroulet L, Ferrante M, Magro F, et al. Results from the 2nd scientific workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis. 2011;5:477–483; (b) Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis Gastroenterology. 2011;141:1194–1201; (c) Reinink AR, Lee TC, Higgins PD. Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis. 2016;22:1859–1869.
  • (a) Schoepfer AM, Beglinger C, Straumann A, et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15:1851–1858; (b) D’Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218–2224.
  • Takashima S, Kato J, Hiraoka S, et al. Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs. fecal immunochemical test. Am J Gastroenterol. 2015;110(6):873–880.
  • Shi HY, Chan FKL, Chan AWH, et al. Accuracy of faecal immunochemical test to predict endoscopic and histological healing in ulcerative colitis: a prospective study based on validated histological scores. J Crohns Colitis. 2017;11(9):1071–1077.
  • Ma C, Lumb R, Walker EV, et al. Noninvasive fecal immunochemical testing and fecal calprotectin predict mucosal healing in inflammatory bowel disease: a prospective cohort study. Inflamm Bowel Dis. 2017;23(9):1643–1649.
  • Mooiweer E, Fidder HH, Siersema PD, et al. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation. Inflamm Bowel Dis. 2014;20(2):307–314.
  • Baars JE, Nuij VJ, Oldenburg B, et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis. 2012;18(9):1634–1640.
  • Shi HY, Chan FKL, Tsang SWC, et al. Factors associated with mucosal healing in patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis. 2015;21(4):840–846.
  • von Martels JZH, Bourgonje AR, Harmsen HJM, et al. Assessing intestinal permeability in Crohn’s disease patients using orally administered 52Cr-EDTA. PLoS One. 2019;14(2):e0211973.
  • Kato J, Hiraoka S, Nakarai A, et al. Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin? Intest Res. 2016;14(1):5–14.
  • Nakarai A, Hiraoka S, Takahashi S, et al. Simultaneous measurements of faecal calprotectin and the faecal immunochemical test in quiescent ulcerative colitis patients can stratify risk of relapse. J Crohns Colitis. 2018;12(1):71–76.
  • (a) Sandborn WJ, Colombel JF, Ghosh S, et al. Eldelumab [anti-IP-10] induction therapy for ulcerative colitis: a randomised, placebo-controlled, phase 2b study. J Crohns Colitis. 2016;10:418–428; (b) Adedokun OJ, Sandborn WJ, Feagan BG, et al. Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis. Gastroenterology. 2014;147:1296–1307 e1295; (c) Colombel JF, Sandborn WJ, Ghosh S, et al. Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: data from ULTRA 1, 2, and 3. Am J Gastroenterol. 2014;109:1771–1780.
  • (a) Boal Carvalho P, Dias de Castro F, Rosa B, et al.. Mucosal healing in ulcerative colitis–when zero is better.J Crohns Colitis. 2016;10:20–25; (b) Barreiro-de Acosta M, Vallejo N, de la Iglesia D, et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (mayo 0 vs 1): a longitudinal cohort study. J Crohns Colitis. 2016;10:13–19.
  • Hiraoka S, Kato J, Nakarai A, et al. Consecutive measurements by faecal immunochemical test in quiescent ulcerative colitis patients can detect clinical relapse. J Crohns Colitis. 2016;10(6):687–694.
  • Patel A, Panchal H, Dubinsky MC. Fecal calprotectin levels predict histological healing in ulcerative colitis. Inflamm Bowel Dis. 2017;23(9):1600–1604.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.